Medical or surgical treatment for chronic gastrooesophageal reflux? A systematic review of published evidence of effectiveness.

P C Allgood, M Bachmann
{"title":"Medical or surgical treatment for chronic gastrooesophageal reflux? A systematic review of published evidence of effectiveness.","authors":"P C Allgood,&nbsp;M Bachmann","doi":"10.1080/110241500750008475","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To compare the effectiveness of medical (antacids, histamine antagonists and proton pump inhibitors) and surgical (fundoplication) treatment of chronic GORD.</p><p><strong>Subjects: </strong>Patients with objective (endoscopic or pH) evidence of chronic reflux reported in 6 randomised trials and 3 cohort studies, 1966-1999.</p><p><strong>Methods: </strong>Systematic review of comparative studies identified from electronic searches, citations, manual searches of journals, and correspondence with authors and experts.</p><p><strong>Main outcome measures: </strong>Improvements in prevalence or severity of symptoms, oesophagitis, pH reflux duration, lower oesophageal sphincter pressure, patients' satisfaction, and side-effects.</p><p><strong>Results: </strong>Improved outcomes were more common after surgical than medical treatment with significant differences in objective outcomes in 5/6 randomised trials and in 2/3 cohort studies. Subjective outcomes (symptoms and patients' satisfaction) were also more common among surgical patients in all but one study that assessed them. Odds ratios for improvement with surgical rather than medical treatment ranged from 1.2 to 200, and numbers needed to treat ranged from 1.2 to 58, where these could be calculated. Studies were too heterogeneous for meta-analysis.</p><p><strong>Conclusions: </strong>In trials of chronic severe GORD, surgery is consistently more effective than medical treatment in relieving symptoms and objective oesophagitis, although omeprazole can give similar symptom relief with adjustment of the dose.</p>","PeriodicalId":22411,"journal":{"name":"The European journal of surgery = Acta chirurgica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/110241500750008475","citationCount":"44","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The European journal of surgery = Acta chirurgica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/110241500750008475","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 44

Abstract

Objective: To compare the effectiveness of medical (antacids, histamine antagonists and proton pump inhibitors) and surgical (fundoplication) treatment of chronic GORD.

Subjects: Patients with objective (endoscopic or pH) evidence of chronic reflux reported in 6 randomised trials and 3 cohort studies, 1966-1999.

Methods: Systematic review of comparative studies identified from electronic searches, citations, manual searches of journals, and correspondence with authors and experts.

Main outcome measures: Improvements in prevalence or severity of symptoms, oesophagitis, pH reflux duration, lower oesophageal sphincter pressure, patients' satisfaction, and side-effects.

Results: Improved outcomes were more common after surgical than medical treatment with significant differences in objective outcomes in 5/6 randomised trials and in 2/3 cohort studies. Subjective outcomes (symptoms and patients' satisfaction) were also more common among surgical patients in all but one study that assessed them. Odds ratios for improvement with surgical rather than medical treatment ranged from 1.2 to 200, and numbers needed to treat ranged from 1.2 to 58, where these could be calculated. Studies were too heterogeneous for meta-analysis.

Conclusions: In trials of chronic severe GORD, surgery is consistently more effective than medical treatment in relieving symptoms and objective oesophagitis, although omeprazole can give similar symptom relief with adjustment of the dose.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性胃食管反流是药物治疗还是手术治疗?对已发表的有效性证据进行系统回顾。
目的:比较药物(抗酸剂、组胺拮抗剂和质子泵抑制剂)与手术(基底复制)治疗慢性GORD的疗效。研究对象:1966-1999年6项随机试验和3项队列研究中有客观(内窥镜或pH值)证据的慢性反流患者。方法:系统回顾从电子检索、引文、期刊手工检索以及与作者和专家的通信中确定的比较研究。主要结局指标:症状的患病率或严重程度、食管炎、pH反流持续时间、食管括约肌压力降低、患者满意度和副作用的改善。结果:在5/6的随机试验和2/3的队列研究中,手术后改善的结果比药物治疗后改善的结果更常见,客观结果有显著差异。主观结果(症状和患者满意度)在手术患者中也更为常见,只有一项研究对其进行了评估。手术治疗比药物治疗改善的优势比在1.2到200之间,需要治疗的人数在1.2到58之间,这些可以计算出来。研究的异质性太大,无法进行meta分析。结论:在慢性重度GORD的试验中,手术在缓解症状和客观食管炎方面始终比药物治疗更有效,尽管奥美拉唑在调整剂量后也能起到类似的症状缓解作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Influence of surgeon's volume on early outcome after total gastrectomy. Prospective evaluation of laparoscopic and open 360 degree fundoplication in mild and severe gastro-oesophageal reflux disease. Factors that affect the variability in heart rate during endoscopic retrograde cholangiopancreatography. Risk factors for severe postoperative hypocalcaemia after operations for primary hyperparathyroidism. Effects of the tyrosine kinase inhibitor tyrphostin AG 556 on acute necrotising pancreatitis in rats.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1